// App-Quantinova.ai

e16534 : Prospective evaluation of the cardiovascular safety profile of abiraterone acetate (AA) in mCRPC patients (pts).

Researchers

Presenter

  • Veronica Prati

Principal Investigators

  • Fiorella Ruatta

  • Angela Gernone

  • Caterina Aversa

  • Danilo Galizia

  • Sofia Torino

  • Laura Marandino

  • Imperia Nuzzolese

  • Alessandro Bonzano

  • Massimo Aglietta

  • Cinzia Ortega

Medical Centers

  • Medical Oncology I Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo, Turin, Italy

  • Medical Oncology I Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo, Turin, Italy

  • Medical Oncology Unit, Policlinico Hospital Bari, Bari, Italy

  • Medical Oncology I Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo, Turin, Italy

  • Medical Oncology I Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo, Turin, Italy

  • Medical Oncology I Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo, Turin, Italy

  • Medical Oncology I Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo, Turin, Italy

  • Cardiology Unit Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo, Candiolo, Italy

  • Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia, IRCCS, Candiolo, Italy

  • Medical Oncology I Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo, Turin, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Cardiotoxicity

  • Congestive heart failure

  • Dyslipidemia

  • Hypertension

  • Diabetes

  • Obesity

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • CB-7598

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved